[144] JOHNSON & JOHNSON SEC Filing

Rhea-AI Filing Summary

Johnson & Johnson (JNJ) filed a Form 144 notice covering a proposed sale of 21,721 shares of common stock with an aggregate market value of $4,185,794.26. The filing lists an approximate sale date of 10/17/2025 on the NYSE through Fidelity Brokerage Services LLC.

The securities were acquired on 10/17/2025 via an option granted on 02/15/2024, with payment made on 10/17/2025 in cash. The notice states 2,408,338,872 shares outstanding. Over the past three months, John C. Reed sold 19,137 shares on 07/17/2025 for gross proceeds of $3,129,830.51.

Insights

Securities law analyst

Routine Form 144 for insider sales; limited market impact signals.

Form 144 is a notice of intent to sell restricted or control securities under Rule 144. Here, the notice lists 21,721 shares of JNJ common stock with an aggregate market value of $4,185,794.26, to be sold approximately on 10/17/2025 via Fidelity Brokerage Services LLC on the NYSE.

The filing notes acquisition on 10/17/2025 from an option granted on 02/15/2024, paid in cash on the same date. It also records 2,408,338,872 shares outstanding and a prior sale in the last three months of 19,137 shares for $3,129,830.51 on 07/17/2025. Actual sales, volume, and timing depend on market conditions and seller decisions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21721	4185794.26	2408338872	10/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/17/2025	Option Granted 02/15/2024	Issuer			21721	10/17/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John C. Reed One Johnson & Johnson Plaza New Brunswick NJ 08933	Common	07/17/2025	19137	3129830.51

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does JNJ’s Form 144 filing disclose?

It notices an intended sale of 21,721 shares of Johnson & Johnson common stock with an aggregate market value of $4,185,794.26.

When and where are the JNJ shares expected to be sold?

The filing lists an approximate sale date of 10/17/2025 on the NYSE.

Who is the broker listed for the JNJ Form 144 sale?

The broker is Fidelity Brokerage Services LLC.

How were the JNJ shares acquired according to the filing?

They were acquired on 10/17/2025 via an option granted on 02/15/2024, with cash payment on 10/17/2025.

How many JNJ shares are outstanding per the notice?

The notice states 2,408,338,872 shares outstanding.

Were there recent JNJ share sales by the same person?

Yes. John C. Reed sold 19,137 shares on 07/17/2025 for gross proceeds of $3,129,830.51.